| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(R) | 313 | 38.7% | -0.94 | 163 | 44.9% |
| CRE(R) | 181 | 22.4% | -0.63 | 117 | 32.2% |
| CA(R) | 145 | 17.9% | -3.86 | 10 | 2.8% |
| CentralBrain-unspecified | 84 | 10.4% | -1.26 | 35 | 9.6% |
| SLP(R) | 37 | 4.6% | -2.40 | 7 | 1.9% |
| PED(R) | 15 | 1.9% | -0.74 | 9 | 2.5% |
| SCL(R) | 19 | 2.4% | -2.66 | 3 | 0.8% |
| b'L(R) | 7 | 0.9% | 0.89 | 13 | 3.6% |
| bL(R) | 4 | 0.5% | 0.32 | 5 | 1.4% |
| SMP(R) | 1 | 0.1% | 0.00 | 1 | 0.3% |
| ICL(R) | 1 | 0.1% | -inf | 0 | 0.0% |
| PLP(R) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg-s3 | % In | CV |
|---|---|---|---|---|---|
| KCg-d (R) | 74 | DA | 223 | 29.7% | 1.5 |
| KCg-m (R) | 79 | DA | 87 | 11.6% | 0.3 |
| PAM08 (R) | 10 | DA | 46 | 6.1% | 1.1 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 40 | 5.3% | 0.0 |
| LHPV3c1 (R) | 1 | ACh | 35 | 4.7% | 0.0 |
| APL (R) | 1 | GABA | 31 | 4.1% | 0.0 |
| KCg-s2 (R) | 1 | DA | 26 | 3.5% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 21 | 2.8% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 21 | 2.8% | 0.0 |
| VP1m_l2PN (R) | 1 | ACh | 18 | 2.4% | 0.0 |
| PAM08 (L) | 9 | DA | 18 | 2.4% | 0.5 |
| PPL103 (R) | 1 | DA | 17 | 2.3% | 0.0 |
| DPM (R) | 1 | DA | 16 | 2.1% | 0.0 |
| PPL103 (L) | 1 | DA | 15 | 2.0% | 0.0 |
| KCg-s1 (R) | 1 | DA | 13 | 1.7% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 12 | 1.6% | 0.0 |
| SLP360_b (R) | 1 | ACh | 11 | 1.5% | 0.0 |
| PAM05 (R) | 3 | DA | 8 | 1.1% | 0.5 |
| OA-VPM3 (L) | 1 | OA | 7 | 0.9% | 0.0 |
| PAM07 (R) | 5 | DA | 7 | 0.9% | 0.6 |
| MBON05 (L) | 1 | Glu | 6 | 0.8% | 0.0 |
| KCa'b'-ap1 (R) | 6 | DA | 6 | 0.8% | 0.0 |
| SMP146 (L) | 1 | GABA | 5 | 0.7% | 0.0 |
| MBON32 (R) | 1 | GABA | 3 | 0.4% | 0.0 |
| PPL101 (L) | 1 | DA | 3 | 0.4% | 0.0 |
| PPL101 (R) | 1 | DA | 3 | 0.4% | 0.0 |
| PAM12 (R) | 2 | DA | 3 | 0.4% | 0.3 |
| PAM05 (L) | 2 | DA | 3 | 0.4% | 0.3 |
| PAM07 (L) | 2 | DA | 3 | 0.4% | 0.3 |
| KCab-p (R) | 2 | DA | 3 | 0.4% | 0.3 |
| WED182 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| MBON09 (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| LHPV6k1 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| PPL202 (R) | 1 | DA | 2 | 0.3% | 0.0 |
| OA-VPM4 (L) | 1 | OA | 2 | 0.3% | 0.0 |
| PFR_a (L) | 2 | unc | 2 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 2 | OA | 2 | 0.3% | 0.0 |
| SMP075 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE027 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MBON21 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON33 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| VP5+Z_adPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB4155 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| PAM06 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| PAM01 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| PAM12 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| M_lPNm13 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP360_c (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_l2PNm17 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_lPNm11D (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a1_a (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MB-C1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP1m+_lvPN (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE048 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV3f1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LAL100 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| PPL201 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| SLP438 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MBON26 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns KCg-s3 | % Out | CV |
|---|---|---|---|---|---|
| KCg-d (R) | 71 | DA | 202 | 21.0% | 1.4 |
| KCg-m (R) | 101 | DA | 125 | 13.0% | 0.4 |
| PAM08 (R) | 17 | DA | 66 | 6.8% | 1.0 |
| MBON05 (L) | 1 | Glu | 57 | 5.9% | 0.0 |
| APL (R) | 1 | GABA | 46 | 4.8% | 0.0 |
| DPM (R) | 1 | DA | 45 | 4.7% | 0.0 |
| MBON09 (R) | 2 | GABA | 33 | 3.4% | 0.0 |
| MBON11 (R) | 1 | GABA | 30 | 3.1% | 0.0 |
| MBON26 (R) | 1 | ACh | 30 | 3.1% | 0.0 |
| MBON33 (R) | 1 | ACh | 24 | 2.5% | 0.0 |
| KCg-s2 (R) | 1 | DA | 24 | 2.5% | 0.0 |
| PAM08 (L) | 9 | DA | 20 | 2.1% | 0.8 |
| PAM07 (R) | 6 | DA | 19 | 2.0% | 0.5 |
| CRE200m (L) | 3 | Glu | 14 | 1.5% | 0.4 |
| MBON21 (R) | 1 | ACh | 12 | 1.2% | 0.0 |
| MBON32 (R) | 1 | GABA | 10 | 1.0% | 0.0 |
| MBON35 (R) | 1 | ACh | 10 | 1.0% | 0.0 |
| PPL103 (R) | 1 | DA | 10 | 1.0% | 0.0 |
| MBON04 (L) | 1 | Glu | 8 | 0.8% | 0.0 |
| KCg-s1 (R) | 1 | DA | 8 | 0.8% | 0.0 |
| PPL101 (L) | 1 | DA | 8 | 0.8% | 0.0 |
| MBON29 (R) | 1 | ACh | 7 | 0.7% | 0.0 |
| PPL104 (R) | 1 | DA | 7 | 0.7% | 0.0 |
| OA-VPM4 (L) | 1 | OA | 7 | 0.7% | 0.0 |
| KCa'b'-ap1 (R) | 7 | DA | 7 | 0.7% | 0.0 |
| CRE048 (R) | 1 | Glu | 6 | 0.6% | 0.0 |
| MBON27 (R) | 1 | ACh | 5 | 0.5% | 0.0 |
| MBON30 (R) | 1 | Glu | 5 | 0.5% | 0.0 |
| CRE080_d (R) | 1 | ACh | 5 | 0.5% | 0.0 |
| CRE080_c (R) | 1 | ACh | 5 | 0.5% | 0.0 |
| LHPV3c1 (R) | 1 | ACh | 5 | 0.5% | 0.0 |
| PPL103 (L) | 1 | DA | 5 | 0.5% | 0.0 |
| PAM12 (R) | 3 | DA | 5 | 0.5% | 0.3 |
| PAM07 (L) | 4 | DA | 5 | 0.5% | 0.3 |
| SMP376 (R) | 1 | Glu | 4 | 0.4% | 0.0 |
| MBON22 (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| MBON22 (R) | 1 | ACh | 4 | 0.4% | 0.0 |
| CRE040 (R) | 1 | GABA | 4 | 0.4% | 0.0 |
| KCab-p (R) | 4 | DA | 4 | 0.4% | 0.0 |
| MBON12 (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| FB4C (R) | 1 | Glu | 3 | 0.3% | 0.0 |
| LHPV7c1 (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| MBON31 (R) | 1 | GABA | 3 | 0.3% | 0.0 |
| PPL101 (R) | 1 | DA | 3 | 0.3% | 0.0 |
| PAM05 (R) | 3 | DA | 3 | 0.3% | 0.0 |
| SMP179 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CRE105 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SMP146 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| mALD3 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| PPL102 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LAL198 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CRE072 (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| KCa'b'-ap2 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| LAL110 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP075 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHCENT3 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE023 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV1c2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE049 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM13 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| CRE081 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1478 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE052 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE044 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE043_c1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| FB4R (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE003_b (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV4c1_b (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| PFR_a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| VP1m+VP2_lvPN2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE067 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE066 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE105 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB0951 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE060 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1454 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP1m+_lvPN (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP116 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| IB115 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe26 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP152 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| CRE100 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON21 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON20 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| SMP108 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
